Levels of HIV-1 persistence on antiretroviral therapy are not associated with markers of inflammation or activation
Author(s) -
Rajesh T. Gandhi,
Deborah McMahon,
Ronald J. Bosch,
Christina M. Lalama,
Joshua C. Cyktor,
Bernard Macatangay,
Charles R. Rinaldo,
Sharon A. Riddler,
Evelyn Hogg,
Catherine Godfrey,
Ann C. Collier,
Joseph J. Eron,
John W. Mellors
Publication year - 2017
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/89ey-rm15
Subject(s) - persistence (discontinuity) , antiretroviral therapy , inflammation , human immunodeficiency virus (hiv) , medicine , immunology , virology , viral load , geotechnical engineering , engineering
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom